Free Trial

Walgreens Boots Alliance (WBA) Stock Price, News & Analysis

$11.82
+0.31 (+2.69%)
(As of 07/26/2024 ET)
Today's Range
$11.37
$11.83
50-Day Range
$10.79
$17.82
52-Week Range
$10.69
$31.32
Volume
14.50 million shs
Average Volume
25.25 million shs
Market Capitalization
$10.20 billion
P/E Ratio
N/A
Dividend Yield
8.46%
Price Target
$16.86

Walgreens Boots Alliance MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.88 Rating Score
Upside/​Downside
42.6% Upside
$16.86 Price Target
Short Interest
Bearish
9.58% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-2.09
Upright™ Environmental Score
News Sentiment
0.13mentions of Walgreens Boots Alliance in the last 14 days
Based on 47 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-25.78%
From $2.87 to $2.13 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.69 out of 5 stars

Retail/Wholesale Sector

27th out of 201 stocks

Drug Stores & Proprietary Stores Industry

2nd out of 4 stocks

WBA stock logo

About Walgreens Boots Alliance Stock (NASDAQ:WBA)

Walgreens Boots Alliance Inc. is a world-renowned healthcare, pharmacy, and retailing company. Founded in 1901 by John Boot and Charles R. Walgreen, the company has grown to become a leader in the industry, operating in nine countries and providing access to healthcare services to millions of people around the world. Walgreens Boots Alliance operates through three main segments: U.S. Retail Pharmacy, International, and U.S. Healthcare.

The U.S. Retail Pharmacy segment includes the Walgreens business, which operates health and wellness services, retail drugstores, specialty and home delivery pharmacy services, and an equity method investment in AmerisourceBergen. Walgreens stores have locations in all 50 U.S. states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands, offering access to consumer goods and services, pharmacy, photo department, and health and wellness services. Walgreens also operates online stores like Walgreens.com, Drugstore.com, VisionDirect.com, and Beauty.com.

The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution company in Germany. This segment includes the Boots brand, which has a history stretching back over 170 years in the United Kingdom, and stores in Ireland and Thailand with Boots franchise operations in the Middle East and Indonesia. The remainder of the division comprises Farmacias Ahumada (FASA) pharmacies in Chile and Benavides in Mexico. The Pharmaceutical Wholesale Division, including the Alliance Healthcare brand, supplied medicines and other healthcare products to more than 115,000  doctors, health centers,  pharmacies, and hospitals annually in eleven countries through 306 distribution centers. AmerisourceBergen purchased most of the Alliance Healthcare wholesale division in June 2021 for $6.275bn in cash.

The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omnichannel experience across the care journey. This segment includes the operation of 334 VillageMD clinics, including 146 co-located clinics, 124 standalone clinics, and 64 affiliate clinics.

Walgreens Boots Alliance produces many brands, including Soltan and Botanics, Boots Pharmaceuticals, and Boots Laboratories, No. 7, that Alliance Boots and Walgreens sought to launch internationally following the first share purchase in 2012. These brands include the famous No. 7 beauty serums, developed in Nottingham, the UVA 5-star suncare protection by Soltan, and the Botanics range, developed in partnership with the Royal Botanic Gardens, Kew. Boots' brand range includes medicines, healthcare products, skincare, and many more. Walgreens also has a self-branded line of products called "Well at Walgreens."

For the fiscal year 2020, Walgreens Boots Alliance reported earnings of US$456 million. The reported revenue was US$139.5 billion, an increase of 2.5% over the previous fiscal cycle. As of 2022, Walgreens Boots Alliance is ranked #18 on the Fortune 500 rankings. The company pays a Quarterly dividend of $0.48, representing an annual dividend yield of 5.08%. Wall Street analysts consider Walgreens stock to be Undervalued. 

Walgreens Boots Alliance has 862,503,540 shares outstanding, and its market cap is currently $31.99B. The company’s EPS estimate is $1.12, and its most recent earnings report saw it beat expectations with an EPS of $1.16. Following the earnings report, the stock price went down -6.135%. Among the most significant hedge funds holding Walgreens Boots Alliance’s shares is Antipodes Partners Ltd., which owns shares valued at $58M.

Walgreens Boots Alliance is a global healthcare leader committed to providing high-quality services and products to its customers. The company’s innovative strategies have earned it a reputation as a reliable and reputable partner for healthcare providers and consumers. With its wide array of products and services, Walgreens Boots Alliance is well-positioned to continue growing and meeting the needs of its customers for years to come.

WBA Stock Price History

WBA Stock News Headlines

Adobe logo sign
3 Recent Stock Buybacks: Adobe, Marathon, and FedEx Lead the Way (WBA)
Three companies are starting to buy back stock this quarter, and financial strength in their companies lets them do this. Wall Street analysts see more upside
walgreens logo sign on storefront
What's Behind Walgreens Stock Plunge: What Investors Can Do Next
After years of a downtrend in their price, shares of Walgreens Boots Alliance Inc. NASDAQ: WBA have thrown in the towel this time. In a single day, the stock is down over 25% in a sign that can't be taken in any other way than a ‘run' message.
How to build the ultimate dividend portfolio
There’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.
walgreens logo sign on storefront
What's Behind Walgreens Stock Plunge: What Investors Can Do Next (WBA)
Shares of Walgreens are down over 25% in a single day, pushing investors to seek an answer. There is a lateral play that can be considered for income here
Ocala, Florida 4-9-2024 Walgreens Drug Store red logo, signage, facade exterior entrance with blue sky and clouds background. Walgreens is an American company that operates a pharmacy store chain.
Walgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts Ahead
Walgreens Boots Alliance NASDAQ: WBA is a global leader in integrated healthcare, pharmacy, and retail. The company recently released its earnings report for the third quarter of 2024, raising questions about its ability to navigate a challenging market environment and achieve sustainable growth.
Ocala, Florida 4-9-2024 Walgreens Drug Store red logo, signage, facade exterior entrance with blue sky and clouds background. Walgreens is an American company that operates a pharmacy store chain.
Walgreens Stock Falls on Q3 Earnings Miss, Strategic Shifts Ahead
Walgreens Boots Alliance faces market challenges, leading to missed earnings expectations and strategic changes to improve profitability.
A currency trader passes by the screen showing the Korea Composite Stock Price Index…
Stock market today: Asian shares advance ahead of U.S. inflation report
Asian shares have advanced as traders look ahead to a key report on inflation that could influence the Federal Reserve’s next move on interest rates
Financial markets news icon
How major US stock indexes fared Thursday, 6/27/2024
Stocks inched higher on Wall Street as markets wait for a key report on inflation
How to build the ultimate dividend portfolio
There’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.
Jen Trejo holds a photo of her son Christopher as she is comforted outside the Supreme Court where …
The legal odyssey for OxyContin maker Purdue Pharma and its owners is complex. Here's what to know
The Supreme Court has rejected a settlement for OxyContin maker Purdue Pharma and members of the Sackler family who own the company
Walgreens says a quarter of US stores are underperforming and it plans to shutter a significant number within 3 years
Walgreens says a quarter of US stores are underperforming and it plans to shutter a significant number within 3 years
A Walgreens store in Bradenton, Fla
Walgreens woes continue with earnings miss, guidance cut and plans to shutter more stores
Walgreens shares tumbled early Thursday after the drugstore chain signaled that more store closings are on the way, missed earnings expectations for its third quarter and cut its annual forecast
Should You Buy the 3 Worst S&P 500 Stocks in Q2?
See More Headlines
Receive WBA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Walgreens Boots Alliance and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/12 Dividend
5/20/2024
Dividend Payable
6/12/2024
Last Earnings
6/27/2024
Today
7/26/2024
Ex-Dividend for 9/12 Dividend
8/21/2024
Fiscal Year End
8/31/2024
Dividend Payable
9/12/2024
Next Earnings (Estimated)
10/10/2024

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
Current Symbol
NASDAQ:WBA
CUSIP
93142210
Employees
331,000
Year Founded
2014

Price Target and Rating

Average Stock Price Target
$16.86
High Stock Price Target
$30.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+42.6%
Consensus Rating
Reduce
Rating Score (0-4)
1.88
Research Coverage
16 Analysts

Profitability

Net Income
$-3,080,000,000.00
Pretax Margin
-9.34%

Debt

Sales & Book Value

Annual Sales
$139.08 billion
Cash Flow
$6.99 per share
Book Value
$17.67 per share

Miscellaneous

Free Float
713,065,000
Market Cap
$10.20 billion
Optionable
Optionable
Beta
0.72

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Should I Buy Walgreens Boots Alliance Stock? WBA Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Walgreens Boots Alliance, Inc.:

  • Walgreens Boots Alliance reported earnings per share of $1.20 for the quarter, surpassing the consensus estimate by $0.38, indicating strong financial performance.
  • The company had a positive return on equity of 12.11%, showcasing efficient utilization of shareholder funds to generate profits.
  • Recent insider transactions, such as Director and CFO stock purchases, signal confidence in the company's future prospects, which can be viewed positively by investors.
  • Walgreens Boots Alliance's quarterly revenue increased by 6.3% compared to the same period last year, demonstrating growth potential.
  • The company pays a quarterly dividend with a yield of 6.39%, providing investors with a steady income stream.

Cons

Investors should be bearish about investing in Walgreens Boots Alliance, Inc. for these reasons:

  • The company's net margin was negative at -4.18%, indicating challenges in profitability and cost management.
  • Walgreens Boots Alliance's dividend payout ratio is currently -14.29%, suggesting that the company may not be utilizing its earnings effectively to distribute dividends.
  • Institutional inflows and outflows show mixed investor sentiment, with some institutions increasing their stake while others reducing it, reflecting uncertainty in the market regarding the company's future performance.
  • While the stock price may seem attractive, investors should consider the overall financial health and long-term growth prospects of the company before making investment decisions.
  • Analysts forecasted earnings per share of 3.21 for the current fiscal year, which may indicate challenges in meeting expectations and sustaining growth.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, June 28, 2024. Please send any questions or comments about these Walgreens Boots Alliance pros and cons to contact@marketbeat.com.

WBA Stock Analysis - Frequently Asked Questions

How have WBA shares performed this year?

Walgreens Boots Alliance's stock was trading at $26.11 at the beginning of the year. Since then, WBA stock has decreased by 54.7% and is now trading at $11.82.
View the best growth stocks for 2024 here
.

How were Walgreens Boots Alliance's earnings last quarter?

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) released its quarterly earnings results on Thursday, June, 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing the consensus estimate of $0.68 by $0.05. Walgreens Boots Alliance's quarterly revenue was up 2.8% on a year-over-year basis.
Read the conference call transcript
.

What is Stefano Pessina's approval rating as Walgreens Boots Alliance's CEO?

4,267 employees have rated Walgreens Boots Alliance Chief Executive Officer Stefano Pessina on Glassdoor.com. Stefano Pessina has an approval rating of 32% among the company's employees. This puts Stefano Pessina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Does Walgreens Boots Alliance have any subsidiaries?

Walgreens Boots Alliance subsidiaries include these companies: Shields Health Solutions, Innovation Associates Inc, Sinopharm Holding GuoDa Drug Store Co., Liz Earle Beauty, Take Care Health Employer Solutions, Alliance Boots Holdings Limited, Alliance Healthcare Deutschland AG, and more.

Who are Walgreens Boots Alliance's major shareholders?

Walgreens Boots Alliance's top institutional shareholders include Bank of New York Mellon Corp (0.62%), Sumitomo Mitsui Trust Holdings Inc. (0.31%), Greylin Investment Management Inc (0.08%) and New York State Teachers Retirement System (0.07%). Insiders that own company stock include Walgreens Boots Alliance, Inc, Timothy C Wentworth, Rosalind G Brewer, Manmohan Mahajan, Richard P Gates, John Patrick Driscoll, Kevin M Ban, Valerie B Jarrett, Inderpal S Bhandari and Nancy M Schlichting.
View institutional ownership trends
.

How do I buy shares of Walgreens Boots Alliance?

Shares of WBA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Walgreens Boots Alliance own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), Walt Disney (DIS), Cisco Systems (CSCO) and AbbVie (ABBV).

This page (NASDAQ:WBA) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners